Weekly injections of the GLP-1 semaglutide reduce alcohol consumption in patients with obesity seeking treatment for alcohol ...
Research indicates semaglutide can significantly decrease alcohol consumption and cravings in individuals with comorbid ...
The study found that the active ingredient in GLP-1 drugs "significantly improved" motivation in patients with major ...
Compared with placebo, semaglutide achieved larger reductions in heavy-drinking days (−41.1 vs −26.4 percentage points) and ...
As weight‑loss drugs surge in popularity, a study raises a new question about what patients may be losing along the way.
Glucagon-like peptide-1 receptor agonists, known as GLP-1 drugs, are highly effective at helping people lose weight and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results